Jason Sheehan
@jasonpsheehan
Top 1% in the latest rankings avantgardehealth.com/best-brain-spi…
JNO and SSF's Tumor Talk...today was a superb presentation on spinal chordomas. If you missed it, you can still watch it on demand at the Seattle Science Foundation's JNO channel.

JNO is delighted to have Professor Grossman and Professor Gidron for its next Tumor Talk on July 28th from 4-4:30pm EST. It will also be archived on the SSF JNO Tumor Talk channel on Youtube.

Delighted to be part of this new study in the Int J. Stroke

Radiosurgery to treat addiction by targeting the nucleus accumbens (red). A new publication out in Cureus is part of a growing body of studies on functional radiosurgery.

Gynecological Cancer metastatic to the brain. Delighted to join Dr. Mathieu and colleagues in this international, multicenter study published in Neurosurgery.

A new study out in Molecular Neurobiology with good friend and colleague Dr. Pan.


A new AVM study by the MISTA Consortium. UVA was well represented on this study.

In the Journal of Neuro-Oncology, adaptive cranial SRS detailed in a new study by Dr. Prasad and his team.

A comprehensive assessment of SRS just out in Advances in Cancer Research.

Dr. Kotecha and his team published a new study in IJROBP on RICE after proton therapy. The RICE lesions are denoted by the yellow arrows.

In the Journal of Neuro-Oncology, check out the latest study entitled "Predicting attention deficits and functional recovery after glioma resection through functional executive networks: insights from dynamic properties"

JNO's Tumor Talk today....Be sure to Tune in at 4pm ET today.

Congratulations to Jared Chung (UVA SOM 2028) for receiving a Neurosurgical Society of the Virginia's scholarship to study brain metastasis research at UVA with my team including me and Dr. Mantziaris.

Delighted to have my team at UVA be contributors and co-authors on this new study on intracranial AVM outcomes

In the Journal of Neuro-Oncology, the Stanford neurosurgery team studied PIK3CA-mutated meningiomas looking at targeted therapy approaches.
